e-learning
resources
Vienna 2012
Tuesday, 04.09.2012
Distinguishing phenotypes and dealing with comorbidities in primary care
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Comorbidity, hospitalization and mortality in COPD: Results from a longitudinal study
F. Di Stefamo, V. Conti, A. Petroianni, C. Terzano (Pescara, Italy)
Source:
Annual Congress 2012 - Distinguishing phenotypes and dealing with comorbidities in primary care
Session:
Distinguishing phenotypes and dealing with comorbidities in primary care
Session type:
Thematic Poster Session
Number:
3688
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
F. Di Stefamo, V. Conti, A. Petroianni, C. Terzano (Pescara, Italy). Comorbidity, hospitalization and mortality in COPD: Results from a longitudinal study. Eur Respir J 2012; 40: Suppl. 56, 3688
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on acute decompensated pulmonary hypertension
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Related content which might interest you:
Predictors of long-term mortality after hospitalization for COPD; A Scandinavian multicentre study
Source: International Congress 2014 – Longitudinal studies of respiratory disease
Year: 2014
COPD-specific co-morbidity test (COTE) for predicting mortality in COPD – Results of an European, multicenter study
Source: International Congress 2014 – Markers
Year: 2014
Smoking reduction and hospitalization from COPD: a Danish population study
Source: Eur Respir J 2001; 18: Suppl. 33, 484s
Year: 2001
The bronchitic phenotype is related to morbidity and mortality - report from the OLIN COPD study
Source: Annual Congress 2013 –Investigating COPD in longitudinal studies
Year: 2013
Clinical examination and all-cause mortality in non-mild COPD population – prospective study
Source: International Congress 2019 – Long-term evaluation and control of airway diseases
Year: 2019
Comorbidities, hospitalizations and the risk for readmission after AE COPD – Longitudinal study
Source: Annual Congress 2010 - COPD exacerbation
Year: 2010
Risk of cardiovascular events following COPD hospitalisation: Findings from the China Kadoorie Biobank cohort study
Source: International Congress 2015 – COPD and lung function: risk factors and outcomes
Year: 2015
Psychosocial predictors for rapid hospital readmission in COPD: a prospective study
Source: Annual Congress 2009 - Epidemiology of COPD
Year: 2009
GOLD classifications and mortality in COPD: The HUNT study
Source: Annual Congress 2013 –Investigating COPD in longitudinal studies
Year: 2013
Impact of frailty during hospitalized exacerbations of COPD on 90-day readmissions - preliminary data.
Source: International Congress 2018 – Physiotherapy care for patients with acute and chronic respiratory conditions
Year: 2018
Risk factors of re-hospitalisation for a COPD exacerbation: a prospective study
Source: Eur Respir J 2002; 20: Suppl. 38, 402s
Year: 2002
Trends and predictors of asthma costs: results from a 10-year longitudinal study
Source: Eur Respir J 2016; 47: 801-809
Year: 2016
Comorbidities and burden of COPD: A population based case-control study
Source: Annual Congress 2013 –Comorbidities and respiratory disease and late-breaking abstracts
Year: 2013
Risk factors for all-cause mortality in patients with COPD: results from the ETHOS trial
Source: Virtual Congress 2021 – Inhaled treatments for COPD: clinical trials and real-world studies
Year: 2021
15-Year mortality after hospitalization for COPD in a Dutch teaching hospital: Preliminary data from the MORTCOP cohort
Source: International Congress 2016 – Prevalence, prognosis, and risk factors of COPD
Year: 2016
Co-morbidities of adult smokers at risk of COPD evaluated in a 6-year prospective study
Source: International Congress 2015 – COPD: notable points
Year: 2015
RSV increases the risk of first paediatric asthma hospitalisation: whole-of-population cohort study
Source: International Congress 2017 – Determinants of childhood asthma and atopy
Year: 2017
Excess economic burden of comorbidities in COPD: a 15-year population-based study
Source: Eur Respir J, 50 (1) 1700393; 10.1183/13993003.00393-2017
Year: 2017
GOLD classification of COPD and subsequent mortality: findings from a cohort study
Source: Annual Congress 2004 - Burden of obstructive lung diseases: costs, mortality and life impairment
Year: 2004
COPD and risk of cardiovascular disease: A prospective study of 0.5M Chinese adults
Source: International Congress 2015 – COPD and lung function: risk factors and outcomes
Year: 2015
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept